Fabien Reyal
Overview
Explore the profile of Fabien Reyal including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
178
Citations
4230
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dumas E, Jochum F, Coussy F, Hamy A, Majdling A, Houzard S, et al.
J Clin Oncol
. 2025 Mar;
:JCO2401131.
PMID: 40043224
Purpose: Young age is associated with increased risk of recurrence in hormone receptor (HR)-positive early-stage breast cancer (eBC). Lack of adherence to endocrine therapy (ET) is a potential reason for...
2.
Darrigues L, Gaillard T, Sabah J, Saule C, Frank S, de Pauw A, et al.
Bull Cancer
. 2025 Feb;
112(3):286-299.
PMID: 39984363
Introduction: Breast cancer associated with pathogenic variants of BRCA1 and BRCA2 genes requires specific management. This review examines the prognostic benefits, prophylactic surgical strategies, and impact on quality of life...
3.
Mukhtar R, Gottipati S, Yau C, Lopez-Tarruella S, Earl H, Hayward L, et al.
NPJ Breast Cancer
. 2025 Feb;
11(1):14.
PMID: 39948079
Residual Cancer Burden (RCB) after neoadjuvant chemotherapy (NAC) is validated to predict event-free survival (EFS) in breast cancer but has not been studied for invasive lobular carcinoma (ILC). We studied...
4.
Ceccato V, Wallaert L, Michel S, Gaillard T, Girard N, Darrigues L, et al.
Sci Rep
. 2025 Feb;
15(1):5002.
PMID: 39930014
Wire guided localization is widely used as the standard method of pre-operative localization of breast lesions. The aim was to assess outcomes following the introduction of a novel non-wire guided,...
5.
Malhaire C, Umay O, Cockenpot V, Selhane F, Ramtohul T, Reyal F, et al.
Eur Radiol
. 2025 Feb;
PMID: 39920303
Objectives: To predict axillary node residual disease in women treated for node-positive breast cancer (BC) by neoadjuvant therapy (NAT), using breast BI-RADS MRI features and axillary ultrasound at baseline. Material...
6.
Jochum F, Doll M, Hamy A, Donval L, Gougis P, Dumas E, et al.
EClinicalMedicine
. 2025 Jan;
80:103053.
PMID: 39867969
Background: Randomized clinical trials (RCTs) are fundamental to evidence-based medicine, but their real-world impact on clinical practice often remains unmonitored. Leveraging large-scale real-world data can enable systematic monitoring of RCT...
7.
Hotton J, Raimond E, Reyal F, Michel S, Ceccato V, Moubtakir A, et al.
Diagnostics (Basel)
. 2024 Nov;
14(22).
PMID: 39594273
: The aim is to propose a model for predicting occult paraaortic lymph node (PALN) involvement in locally advanced cervical cancer (LACC) patients by including parameters such as reconstruction detection...
8.
Laas E, Dumas E, Hamy A, Gaillard T, Gougis P, Reyal F, et al.
Eur J Surg Oncol
. 2024 Nov;
51(1):109373.
PMID: 39549387
Background: Suboptimal treatment delays is known to impact prognosis of patients with cancer but optimal timing in specific subgroups remains poorly studied. This study aimed to analyze treatment delays in...
9.
Houvenaeghel G, Classe J, Chauvet M, Colombo P, Jouve E, Reyal F, et al.
Cancers (Basel)
. 2024 Oct;
16(19).
PMID: 39409937
Despite early diagnosis, approximately 20% of patients with ER-positive and HER2-negative breast cancer (BC) will experience disease recurrence. Improved survival has been reported with adjuvant treatment combining cyclin-dependent kinase 4/6...
10.
Delrieu L, Blanc D, Bouhamama A, Reyal F, Pilleul F, Racine V, et al.
Front Nucl Med
. 2024 Oct;
3:1292676.
PMID: 39355015
Introduction: The importance of body composition and sarcopenia is well-recognized in cancer patient outcomes and treatment tolerance, yet routine evaluations are rare due to their time-intensive nature. While CT scans...